Edit Content

Review of Presbyopia and the Aging Eye Staff


MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals

February 14, 2024 LONDON and NEW YORK — MeiraGTx Holdings, a vertically integrated, clinical stage gene therapy company, announced the achievement of the first milestone payment of $50 million under the asset purchase agreement the company entered

Screenshot of Fingeret ROP Video

A Conversation About Glaucoma: History, Research, and Education

January 23, 2024 In this video interview, Dr. Jack Schaeffer, Chief Clinical Editor of Review of Presbyopia and the Aging Eye, talks to Dr. Murray Fingeret, OD, FAAO, the digital publication’s Glaucoma editor, about past and present

Scroll to Top